Clinical trial design : Bayesian and frequentist adaptive methods /
There has been enormous interest and development in Bayesian adaptive designs, especially for early phases of clinical trials. nevertheless, for phase III trials, frequentist methods still play a dominant role through controlling type I and type II errors in the hypothesis testing framework. This bo...
| Κύριος συγγραφέας: | |
|---|---|
| Συγγραφή απο Οργανισμό/Αρχή: | |
| Μορφή: | Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Hoboken, N.J. :
John Wiley & Sons,
[2012]
|
| Σειρά: | Wiley series in probability and statistics.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Front Matter
- Introduction
- Fundamentals of Clinical Trials
- Frequentist versus Bayesian Statistics
- Phase I Trial Design
- Phase II Trial Design
- Phase III Trial Design
- Adaptive Randomization
- Late-Onset Toxicity
- Drug-Combination Trials
- Targeted Therapy Design
- References
- Author Index
- Subject Index
- Wiley Series in Probability and Statistics.
- Fundamentals of clinical trials
- Frequentist versus Bayesian statistics
- Phase I trial design
- Phase II trial design
- Phase III trial design
- Adaptive randomization
- Late onset toxicity
- Drug combination trials
- Targeted therapy design.